A follow up of a phase 2 trial published in eClinicalMedicine looks at the effect of psilocybin versus escitalopram for depression. … read more
A study published in The Lancet Psychiatry looks at antidepressant discontinuation symptoms. Prof Oliver Howes, Chair of the Psychopharmacology Committee at … read more
For some people, when they stop taking antidepressants, they can experience unpleasant symptoms such as dizziness, headache, nausea and insomnia. … read more
Scientists react to Elon Musk claiming that he used ketamine for depression. Dr Rupert McShane, Consultant Psychiatrist at Oxford … read more
A study published in Nature Neuroscience suggests that psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Dr … read more
Millions of people around the world are prescribed antidepressants to treat chronic pain. In many countries, including the UK, regulators … read more
A meta-analysis published by Cochrane looks at the use of antidepressants for pain management in adults with chronic pain. This … read more
A study published in PNAS suggests that antidepressants can induce mutation and enhance persistence towards multiple antibiotics. The following … read more
The National Institute for Health and Care Excellence (NICE) have published a new draft quality standard on treatment of depression. … read more
A study published in JAMA Internal Medicine looks at antidepressant use during pregnancy and risk of neurodevelopmental disorders in children. … read more
A review paper published in Molecular Psychiatry looks at the ‘serotonin theory of depression’. Prof Gitte Moos Knudsen, Professor … read more
A study published in PLOS ONE looks at antidepressants and health-related quality of life (HRQoL) for patients with depression. … read more
An observational study published in JAMA Network Open looks at mortality risk among patients with COVID-19 prescribed selective serotonin reuptake … read more
A new study has looked at the impact of coming off antidepressants in those who have been taking them long … read more
A study published in New England Journal of Medicine (NEJM) looks at maintenance or discontinuation of antidepressants in primary care. … read more
This phase 2 trial is the first head to head comparison of psilocybin against a licenced antidepressant in patients with … read more
A study published in the New England Journal of Medicine looks at phase 2 trail comparing psilocybin, the active compound … read more
The National Institute of Health and Care Excellence (NICE) have announced a second public consultation on its draft guidance which … read more
NICE have issued their draft guidance on Esketamine nasal spray for treatment resistant depression. Dr Paul Keedwell, Consultant Psychiatrist, … read more
A study, published in the journal eneuro, reports on the impact on offspring of SSRI medication use in mouse pregnancy. … read more
